Financial Growth of Square Pharma

In: Other Topics

Submitted By teeloqq
Words 4202
Pages 17


April 20, 2008



April 20, 2008

Members of the Group

A single individual can achieve no noble objective. We are indebted to a number of persons for their kind advice, suggestions, directions, & co-operations which have enable us to prepare this report. First of all I would like to thank Utpual for his contribution into this report. We would like to thank Kazal Pharmacy for their suggestion and ideas.

Riaheen Farzana
Senior Lecturer
ULAB School of Business
University of Liberal Arts Bangladesh
Dhanmondi, Road- 4/A Satmosjid Road,

Subject: Submission of the Report.

Dear Madam,
Here is the Report on Performance of Square Pharmaceuticals Ltd based on the year 2006-2007 Which we the group members studied. We have tried our best to prepare the report in consistence with the optimal standard under your valuable direction.

We would be very grateful if you accept our report modestly as it may suffer from some shortcomings. We desired…...

Similar Documents

Square Pharma

...A. Historical Background: Square is one of the well-known companies in Bangladesh. At present it has a huge number of products and it has employees more than 12000.Square pharmaceutical is a sister company of square group of industries. Mr. Samson H Chowdhury is the founder of this company. In 1952, he started a small pharmacy in Ataikula village, which is about 160 km off capital Dhaka in the northwest part of Bangladesh. Then he ventured into a partnership pharmaceutical company with three of his friends in 1958. They named the company “SQUARE”. They choose this name because four friends started this company and it signifies accuracy and perfection meaning quality. From then square started its journey and become a renowned organization. Eventually this small company of 1958 turned into a publicly listed diversified group of companies and employing more than 12,000 people. The current yearly group turnover is 300 million USD. And now Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991The sales turnover of SPL was more than Taka 7.5 Billion (US$ 107.91 million) with about 16.92% market share (April 2006– March 2007) having a growth rate of about 23.17%. B. Background of the Export: ➢ When, Why & How Square Pharmaceuticals stared its export...

Words: 971 - Pages: 4

Financial Report of Square

... of which 20.5 percent has been proposed for human resource (education, health, and other related sectors) sector. 27.8 percent of total allocation has been proposed for physical infrastructure sector of which 14.9 percent has been proposed for overall agriculture and rural development, 7.0 percent for communication sector, 5.0 percent for power and energy sectors. 19.3 percent of total allocation has been proposed for general services sector. 4.9 percent of total allocation has been proposed for Public-Private Partnership (PPP), financial assistance for different industries, subsidy, and equity investment in nationalised banks and financial institutions. 12.2 percent has been proposed as interest payments. Rest 11.7 percent will be spent for net lending and other expenditures. I hope that the proposed budget in the context of domestic and external environment will support growth , contain inflation and reflect aspirations of the general people. Some Proposals for Import duty, Supplementary duty and VAT for FY2012-13 Table-2: Budget Structure (Year: 2008-09 to 2012-13) (In core Tk.) (Numbers in parentheses are expressed in percentage of GDP) ...

Words: 970 - Pages: 4

Strategy Square Pharma

... views business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization. So, we can say that its Vision is focused on different stakeholders, i.e., People oriented. 1.4 Mission Its Mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large. So, we can say that its Mission is focused on a combination of products & services and different stakeholders, i.e., its mission is a combination of “Product & Service” and “People” focused. 1.5 Objective Its objectives are to conduct transparent business operation based on market mechanism within the legal & social frame work with aims to attain the mission reflected by its vision. 1.6 Corporate Focus Its vision, mission and objectives are to emphasize on the quality of product, process and services leading to growth of the company imbibed with good governance practices. 1.7 Management Philosophy The Philosophies as have been adopted by Square Pharmaceuticals Ltd. are as follows: * Bangladesh should support and respect the protection of internationally proclaimed human rights within their sphere of influence; and * Make sure that they are not complicit in human rights abuses. *......

Words: 3682 - Pages: 15

Financial Analysis of Square Pharma

...Institute of Business Administration (IBA) MBA Admission Test 50th Batch ( Session 2012 – 2013 ) MBA Admission Test (2012 – 13) of the Institute of Business Administration (IBA), University of Dhaka will be held on Friday, June 14, 2013 at 10 am. For all other certificates, equivalence will be determined by the Equivalence Committee of IBA. ELIGIBILITY All applicants must have at least a Bachelor Degree in any field of study. The minimum qualifying point is seven (07) for all applicants. The points are calculated as follows: SELECTION PROCEDURE The test has two components: Written Assessment and Interview. The written assessment component evaluates applicants’ aptitude in Language, Mathematics, and Analytical ability. An applicant must obtain a minimum qualifying score in each of the above areas to pass of the written test and appear for the interview. All Bangladeshi applicants must take the admission test. An applicant with foreign nationality with minimum 70 percentile in GMAT may be exempted from the written assessment. However, they will be required to appear for an interview. SSC and HSC or Equivalents SSC GPA/Div >= 4.0/Ist >= 3.0/2nd >= 1.0/3rd HSC GPA/Div >= 4.0/Ist >= 3.0/2nd >= 1.0/3rd O-level GPA A-level GPA Points Earned 3 2 1 * * >= 3.0 >= 2.5 >= 1.0 >=2.5 >= 2.0 >= 1.0 Applicants who have taken O-Level examination must pass at least five (05) subjects (including mathematics) with a minimum of grade D in each of the subjects...

Words: 458 - Pages: 2

Financial Growth of Square Pharma

... • Product line • Quality Control • Pharmaceutical Sector: • Economic & Environmental Situation: • Corporate Headquarters Financial Reports • Corporate operational Results • Balance Sheet • Income Statement • Cash Flow Performance of SPL • Financial Result • Ratio Analysis • Comparative Balance Sheet • SWOT Analysis • Conclusion And Suggestion Financial Statements • Appendix • Abbreviation • Bibliography List of Figures: Figure 1: Sources of Data Figure 2: Growth Rate Figure 3: Financial Result Figure 4: Ratio Analysis Executive Summary The Square Pharmaceuticals Ltd was established in 1958 initially as a partnership. Then in 1964 it was incorporated as a private limited company. In 1991 it was converted into public limited company. The authorized capital of the company is Tk 1000 million and paid up capital is Tk 496.8 million. Their main aim is to produce & provide quality and innovative health care relief......

Words: 4202 - Pages: 17

Case Study on Square Pharma

... 6.917222222 100001 to 1000000 Shares 14 2935254 67.94569444 Over 1000000 Shares 0 0 0 Total 10486 4320000 100 SQUARE Pharmaceuticals Limited and Its partners Legal Advisors: Rafiqul-ul Huq, Bar-at-law Rokanuddin Mahmud, Bar-at-law Muniruzzaman Khan, Bar-at-law Auditors: M/S Chowdhury Bhattacharjee & Co. Chartered Accountants 47/1, Indira Road Dhaka-1215, Bangladesh 1.4.7 SQUARE is different: SQUARE Pharmaceuticals Limited has extended her range of services towards the highway of global market. She pioneered exports of medicines from Bangladesh in 1981 and has been exporting antibiotics and other pharmaceutical products. This extension in business and services has manifested the credibility of Square Pharmaceuticals Limited. SQUARE STRIVE FOR We inSQUAREstrive, above all, for top quality health care products at the least cost reaching the lowest rungs of the economic class of people in the country. We value our social obligations. We owe to our shareholders and strive for protection of their capital as well as ensure highest return and growth of their assets. We strive for best compensation to all the employees who constitute the back-bone of the management and operational strength of the Company through a pay-package composing salary/wages, allowances, bonus, profit participation, leave salary and superannuation & retirement benefits. We strive for best co-operation of the creditors & debtors the banks &......

Words: 8546 - Pages: 35

Financial Statement Analysis of Square Pharmaceuticals Ltd.

...|FINANCIAL STATEMENT ANALYSIS | Analyzing financial statements involves evaluating three characteristics: a company’s liquidity, profitability and solvency. A short-term creditor such as a bank is primarily interested in liquidity – the borrower to pay obligations when they come due. A long-term creditor, such as a bondholder, looks to profitability and solvency measures that indicate the company’s ability to survive over a long period of time. Similarly, stockholders look at the profitability and solvency of the company and want to assess the likelihood of dividends and the growth potential of the stock. Three commonly used tools for financial statement analysis are: i. Horizontal analysis evaluates a series of financial statement data over a period of time. ii. Vertical analysis evaluates financial statement data by expressing such item in a financial statement as a percentage of a base amount. iii. Ratio analysis expresses the relationship among selected items of financial statement data. BRIEF HISTORY OF SQUARE PHARMACEUTICALS LTD. Square Pharmaceuticals Ltd. is a renowned company in Bangladesh. It is a flagship company in the pharmaceutical industry which has reached this mountain of success by fighting many potential competitors like BEXIMCO Pharma, INCEPTA, ACME, RENETA, OPSONIN, SK+F, SANOFI-AVENTIS etc. It initially started as a Partnership in 1958. It...

Words: 3064 - Pages: 13

Financial Analysis of Wyeth Pharma

... last 5 years to its shareholders via Karachi Stock Exchange. In 2009 the majority share holding was acquired by Pfizer USA but the company has retained its name in Pakistan and functions independently. 5. Financial Summary: Comprehensive statement 2012 Revenues Expenses Expenses Expenses Sales Cost of sales Admin exp Selling exp 3,145,950 2,414,714 76,926 400,260 2011 2,899,363 2,157,447 87,955 386,808 2010 2,310,191 1,829,653 107,938 340,214 2009 2,306,323 1,805,262 167,871 332,283 2008 2,383,639 1,678,989 122,210 328,361 Expenses Expenses Revenues Expenses Expenses Expenses Gross profit Net profit operating profit Earning befor tax Financial exp Other costs Other income Taxation: Current for the years Taxation: Current for prior years Taxation Deferred 877 43,249 34,308 105,213 6,738 731,236 244,232 254,050 244,232 870 33,367 39,929 88,710 123,312 (3,525) 741,916 149,533 267,153 272,845 3,014 6,122 19,979 3,752 43,922 15,174 1,106 90,673 66,789 16,770 55,256 84,797 480,538 26,459 32,386 43,229 501,061 (86,849) 907 (31,593) 704,650 144,292 254,079 229,089 6. Main Competitors in Pakistan: Some of the main competitors in Pakistan are mentioned below; 1. Roche 5.Glaxosmithkline 10. Alcon 2. Reckit &Benckiser 6.Atco Laboratories 11. Pearl Pharmaceuticals 3.Sandoz 7.Getz Pharma 12.Abbot Pakistan 4.Global Pharmaceuticals 8.Bosch 9.Adamjee 7. Share Price in Last 12 Months: Price 1,510 Latest price in PKR...

Words: 4036 - Pages: 17

Financial Analysis of Square Pharma

...Question 1# Principal activities of SQUARE Pharmaceuticals: * Square strives for top quality health care products at the least cost reaching the lowest rungs of the economic class of people in the country. We value our social obligations. * Square owe their shareholders and strive for protection of their capital as well as ensure highest return and growth of their assets. * Square works for best compensation to all the employees who constitute the back-bone of the management and operational strength of the company through a pay-package composing salary/wages, allowances, bonuses, profit participation, leave salary and superannuation & retirement benefits. * Square works for the best co-operation of the creditors & debtors the banks & financial Institutions who provide financial support when we need them, the suppliers of raw materials &suppliers who offer them at the best prices at the opportune moments, the providers of utilities- power, gas & water etc. and the customers who buy our products & services by redeeming their claim in time by making prompt payment and by distributing proper product on due dates to our customers. * Square strives for fulfillment of our responsibility to the government through payment of entire range of due taxes, duties and claims by various public agencies like municipalities etc. * Square works as responsible citizen, for a social order devoid of malpractices, anti-environmental behaviors...

Words: 4003 - Pages: 17

Financial Ratio Analysis of Square Pharmaceuticals Limited

... limited company in 1991. The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71 million) with about 16.43% market share (April 2009– March 2010) having a growth rate of about 16.72% (Square Pharma Web). 2.2. Key Financial Highlights: Before going to the main part of the paper, which is financial ratio analysis of Square Pharmaceuticals Limited, some key financial data about the company can give deep understanding on the company’s financial positions and performance. This chapter contains – 2.1. Overview of the Organization; and 2.2. Key Financial Highlights. Financial Ratio Analysis of Square Pharmaceuticals Limited 8 of 24 2.2.1. Turnover: It may be observed that turnover (net of VAT) have been increased over the year from the 2006-07 to 2010-10. In comparison to the last year turnover increased by 17.52 % where the total industry increased by 23.80% (IMS paper, 2010). In the year 2007-08, 2008-09 and 2009-10 turnover increased by 10.09%, 18.93% and 16.72% respectively. 2.2.2. Net Profit: 7,500,811 8,257,844 9,820,797 11,462,578 13,471,424 0 2,000,000 4,000,000 6,000,000 8,000,000 10,000,000 12,000,000 14,000,000 16,000,000 2006-07 2007-08 2008-09 2009-10 2010-11 Turnover (BDT) 1,303,243 1,381,863 1,890,053 2,087,872 2,532,055 0 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 2006-07 2007-08 2008-09 2009-10 2010-11 Net Profit (BDT) Financial Ratio Analysis of Square Pharmaceuticals Limited 9 of......

Words: 4143 - Pages: 17

Financial Research Report - Acadia Pharma

...Financial Research Report ACADIA Pharmaceuticals Inc. FIN 534 Name Instructor Date ACADIA Pharmaceuticals Inc. Financial Research Report 1.0. Introduction Pharmaceuticals Inc. is a publicly traded company in the United States of America in the biopharmaceutical industry. The company is devoted to discover, develop, and commercialize small molecule drugs that are useful in treating disorders in the central nervous system. The current engagement of the company is in treatment of induced dysfunction in Parkinson's disease, schizophrenia, neuropathic pain and glaucoma. All company product candidates are a product of discoveries made at the company’s discovery platform. There is a strong team with industry experience which is put in place to aid in the development of these products. This team work together with the company’s world-class scientific and clinical advisors who are also hired by the company. It was found in 1993 and has it’s headquarter situated in San Diego, in California. The aim of this paper is to evaluate the performance of the company using ratio and stock price analysis. The financial statements for the year ending 31st December 2012, 2011, and 2010 will be used in this analysis. These are complete financial statements covering the whole financial statements retrieved from yahoo finance. 2.0. Rationale for choosing the company for which to invest This company was selected because of interesting trend in the industry. For the past three years...

Words: 2585 - Pages: 11

Financial Statement Analysis of Square Pharma

...INTRODUCTION: Objectives of the Report: 1. To know the current financial performance of the two companies. 2. To know the future prospect of the companies. 3. To compare the financial position of the two companies. Scope of the report: 1. Studying the pros and cons of the financial statements of a company, it is possible to predict the probable future growth of a company Methodology: Data were collected from Annual Reports of Square Pharmaceuticals Ltd. and Renata Pharmaceuticals Ltd. from the year 2003 to 2008. Three types of financial tools were used to analyze the data which are: 1. Horizontal Analysis 2. Vertical Analysis and 3. Ratio Analysis. LITERATURE REVIEW: Financial Analysis: The art of transforming data from financial statements into information that is useful for informed decision making is financial analysis. Financial analysis involves the use of various financial statements. These statements do several things.  First the balance sheet summarizes the assets, liabilities and owners’ equity of a business at a moment in time usually the end of a year or a quarter. Next the income statement summarizes the revenue and expenses of the firm over a particular period of time, again usually a year or a quarter. Need for Comparative Analysis: Every item reported in a financial statement has significance. We know a company had a certain amount of cash on the balance sheet but we do not know whether the amount represents an increase over prior...

Words: 1445 - Pages: 6

Square Pharma

.... Pharmaceuticals Division 2. Agro Vet Division 3. Chemical Division | 1.2. Human Resource Department of Square Pharmaceutical Ltd SQUARE, with its progressive business outlook, believes and practices corporate work culture with a classic blend of efficiency and equity. SQUARE believes in company growth by increasing efficiency level of employees and for that offering excellent environment and support for skill and knowledge up gradation. SQUARE values productivity as the spontaneous contribution of Human Resources. Strategic Human Resource Development Programs are the energy sources for SQUARE HR for running towards the zenith of success. Flow of clear and specific information and justification of queries play the vital role to ensure the market reputation of SQUARE as the most trusted and transparent company and it enriches the motivation level of HR who are the real contributors and owners of his/her own jobs. At SQUARE, HRD symbolizes the unique blending of professionalism as well as sharing the stress and success equally like a family where every member has deep concern, feelings and pride for their own company SQUARE.HR ensures the strong supporting role to develop & implement HR policy guidelines for ensuring uninterrupted operation and spontaneous participation to achieve organizational objective as well as fulfillment of employee needs. HR is maintaining an effective way to deal with labor union and still no unrest has been recorded as dispute Personnel......

Words: 2745 - Pages: 11

Financial Ratio Analysis of Square Pharma & Beximco Pharma

...|Financial Ratio Analysis | | | |Performing Year: 2008 & 2009 | | | | Beximco Pharmaceuticals ltd. & Square Pharmaceuticals ltd. Submitted by Group Name: Peace Messengers • Islam Mohammad Samiul (09-14649-3) • Hamid Faisal (09- 15037 -3) Course Name: Financial Management Section: H AIUB Letter of Transmittal 01/03/2011 Mrs. Farzana Islam Honorable Faculty A.I.U.B. Dear Madam, It gives us immense pleasure to submit a report on “Financial Ratio Analysis”. This report is submitted as a partial fulfillment/ as a part of our course “Financial Management ”. We have choose two renowned pharmaceuticals companies of the country who are “Beximco Pharmaceuticals Ltd.” and “Square Pharmaceuticals Ltd.”The preparation of the report has given us in-depth knowledge on “Financial Ratio Analysis”. We have given our best effort to make it a worthy one and each aspect of the problem is considered and studied as required. If any confusion arises or further explanation is needed, we shall be available to explain the matter to you as and when required despite having limitations. Your compassionate and...

Words: 2113 - Pages: 9

Square Pharma Business Report

...[pic] [pic] [pic] EXECUTIVE SUMMARY Square Pharmaceutical Limited Bangladesh is one of the leading pharmaceuticals in Bangladesh. SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. Their Future Focus are- • Strengthen its position in the present markets. • Work is in progress to enter into regulated markets in Europe and United States. In this report, we have tried to show you the actual business environment of Square Pharmaceutical Limited Bangladesh. In details we have included company’s basic profile, its annual business report and the background of the organization. CONTENT • Company Profile 5 • Square Pharmaceuticals Ltd. 6-23 • Management 7 • Square Quality Policy 9 • Financial Report 10-17 • Their Products...

Words: 2256 - Pages: 10